Results: BIPROGY Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

BIPROGY Inc. (TSE:8056) just released its latest quarterly results and things are looking bullish. The company beat forecasts, with revenue of JP¥88b, some 6.9% above estimates, and statutory earnings per share (EPS) coming in at JP¥48.66, 33% ahead of expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

View our latest analysis for BIPROGY

Taking into account the latest results, the most recent consensus for BIPROGY from eight analysts is for revenues of JP¥390.2b in 2025. If met, it would imply an okay 3.1% increase on its revenue over the past 12 months. Statutory earnings per share are forecast to decrease 4.9% to JP¥250 in the same period. Before this earnings report, the analysts had been forecasting revenues of JP¥390.0b and earnings per share (EPS) of JP¥249 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

It will come as no surprise then, to learn that the consensus price target is largely unchanged at JP¥4,763. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic BIPROGY analyst has a price target of JP¥5,800 per share, while the most pessimistic values it at JP¥3,800. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We can infer from the latest estimates that forecasts expect a continuation of BIPROGY'shistorical trends, as the 4.1% annualised revenue growth to the end of 2025 is roughly in line with the 4.0% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 4.8% annually. So although BIPROGY is expected to maintain its revenue growth rate, it's only growing at about the rate of the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple BIPROGY analysts - going out to 2027, and you can see them free on our platform here.

Before you take the next step you should know about the 2 warning signs for BIPROGY that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com